1MRKX:BIT
Merck & Co Inc
€128.18
arrow_downward
-0.59%(-0.76) 1D
Oct 2, 5:26:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Citigroup raises target for Merck & Co. stock to USD 145.00
MarketBeat
·
5 hours ago
Merck & Co., Inc. $MRK Stock Holdings Cut by Salem Investment Counselors Inc.
Simply Wall Street
·
23 hours ago
Merck (MRK) Stock Could Be A Bargain As Its 120% Run Continues
Barchart.com
·
1 day ago
Here's What to Expect From Merck & Co.'s Next Earnings Report
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia